ICD-10 Coding for Granulomatosis with Polyangiitis(L98.0P, M31.30, M31.30A)
Learn about ICD-10 coding for granulomatosis with polyangiitis, including documentation requirements and clinical validation criteria.
Complete code families applicable to Granulomatosis with Polyangiitis
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| M31.30 | Wegener's granulomatosis without renal involvement | Use when GPA is diagnosed without renal involvement. |
|
| M31.31 | Wegener's granulomatosis with renal involvement | Use when GPA is diagnosed with renal involvement. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutGranulomatosis with Polyangiitis
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Granulomatosis with Polyangiitis.
Omitting ANCA test results in documentation.
Impact
Clinical: May lead to misdiagnosis or incorrect treatment., Regulatory: Non-compliance with documentation standards., Financial: Potential for claim denials.
Mitigation
Ensure ANCA results are included in all relevant documentation.
Coding GPA without specifying renal involvement.
Impact
Reimbursement: Incorrect coding can lead to reduced reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data affecting patient records.
Mitigation
Ensure documentation clearly states whether renal involvement is present.
ANCA documentation
Impact
Lack of ANCA test documentation can trigger audits.
Mitigation
Ensure all ANCA test results are documented.